Smoking Association with Transmission and Mortality of COVID-19

Authors

  • Ashraf Rizq Yahya Al Qarih (1) *, Saleh Mohammed Ali Al Faraj (2), Nasser Mohammed Salim Al Khuraym (3), Fareed Mahdi Binali Alsallum (4), Ahmed Abdullah Ahmed Alyami (5), Ail Hamad Ail Al Alshahi (6), Amal Abdullah Bin Saad Asiri (7), Moraya Mubark Abdoun (8), Hussain Saif Hussain Alyami (9), Hussain Fares Faraj Alyami (10), Nabelah Ali Sabaan Alyami (11) (1) Laboratory Technician, King Khalid Hospital, Najran. (2) Specialist-Emergency Medical Services, Emergency and Disaster Management and Medical Transportation in Najran. (3) Public Health Specialist, Infection Control Department MOH - Najran Region. (4) Specialist Nursing, Thar Hospital, Najran. (5) Specialist-Emergency Medical Services, New Najran General Hospital MOH - Emergency Department. (6) Specialist-Nursing, Irada Complex for Mental Health in Najran. (7) Specialist-Nursing, King Khalid Hospital, Najran. (8) Laboratory Technician, Regnal Lab, Najran. (9) Epidemiology Technician, King Khalid Hospital, Najran. (10) Specialist-Nursing, New Najran General Hospital, MOH, Najran. (11) Nursing Technician, Hospitality Health Center for Vaccines, Najran.

Keywords:

Smoking, Nicotine, Risk, COVID-19, Transmission, Mortality

Abstract

Introduction: Given the unclear evidence about smoking in COVID-19-infected patients, we conducted a comprehensive review to determine the association between smoking and disease severity in COVID-19-infected patients by including all eligible studies. Systematic searching of databases for available evidence and careful definition of disease severity was performed for a rigorous summary of the conclusions.
Methods: To find relevant studies, scientific databases including Embase, PubMed, Science Direct, Google Scholar, and Cochrane Library databases were systematically searched. All relevant articles that reported clinical characteristics and epidemiological information on smoking among COVID-19-infected patients were included in the analysis. All articles with any design (randomized controlled trials and observational studies) were included. The primary outcome was disease severity among COVID-19 patients with a history of smoking. The secondary outcome was death among COVID-19 patients with a history of smoking.
Results: Studies reporting a low rate of smoking have been criticized for the poor quality and retrospective collection of smoking status data, the comparison of smoking of subjects covid-19 to the smoking of the general population sometimes without taking into account sex and age, and for having included only symptomatic or in-hospital subjects, creating possible selection bias. In this context, it is important to further explore the relationships between smoking and covid-19 and to determine whether these relationships could reflect an effect of nicotine or smoke itself. Among 8910 patients hospitalized for covid-19 (low smoking rate, 6% smokers) researchers observed a greater risk of death for current smokers than non-smokers or former smokers.

Conclusions: Smoking is confirmed to be a risk factor for the negative progression of COVID-19, particularly in disease severity and death. Both current and former smokers have higher odds of disease severity than never-smokers. Given the well-established harm associated with tobacco use, smoking cessation is recommended for all smokers and the avoidance of second-hand smoke by non-smokers.

Downloads

Published

2022-12-20